We sit down with DHL Supply Chain EMEA CEO Hendrik Venter and Managing Director for Türkiye, Buket Cox, to learn why DHL are ...

DHL Group plans to spend ... $5 billion in global revenue in 2024. Investment in the health care sector — including medical device, clinical trial, biopharma, cell and gene therapy logistics ...

Shipping and logistics giant DHL Group is earmarking 2 billion ... in order to meet growing demand from the biopharma industry. Half of the investment will target the Americas with the remaining ...

DHL Group has announced an investment of €2 billion over the next five years to enhance its logistics capabilities in the life sciences and healthcare sector.

We recently published a list of 10 Best German Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

The investment is part of DHL’s recent strategy to double health ... a specialty courier that provides logistics services for clinical trials, biopharma, and cell and gene therapies, for $ ...

Facility part of DHL Group’s €500 million investment in Asia Pacific for the life sciences & healthcare infrastructure.

DHL Group has announced a strategic investment of EUR 2 billion over the next five years to enhance its logistics ...

where to put inventory to best position themselves." He also talks about DHL's investments in Southeast Asia and expansion in healthcare logistics.

Logistics giant has laid in billions for expansion and sees big potential in life sciences and e-commerce Read more at The ...

Investing.com -- DHL Group, the world’s foremost logistics provider, has acquired 100% of CRYOPDP, a specialty courier with a focus on clinical trials, biopharma, and cell and gene therapies. In ...